ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX), a biopharmaceutical company, is dedicated to in-licensing, developing and commercializing proprietary product candidates. Their key focus is on the treatment of cancer. The Company intends to enhance the performance and commercial potential of existing treatments by addressing issues related with these treatment regimens. For further information, visit the Company’s web site at www.adventrx.com.
- 17 years ago
QualityStocks
ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX)
Tags Rodman & Renshaw
Related Post
-
QualityStocksNewsBreaks – NRx Pharmaceuticals, Inc. (NASDAQ: NRXP) Forms Investor Relations Partnership With astr Partners
NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company, and its subsidiary HOPE Therapeutics announced a…
-
QualityStocksNewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) VALID-ECG Study Confirms Diagnostic Accuracy of Synthesized 12-Lead ECG
HeartBeam’s credit card-sized device demonstrated 93.4% diagnostic agreement with standard ECGs VALID-ECG study results presented…
-
QualityStocksNewsBreaks – RedCloud Holdings plc (NASDAQ: RCT) to Participate in ROTH 15th Annual London Conference
RedCloud Holdings (NASDAQ: RCT) announced that CEO and Co-Founder Justin Floyd will attend the ROTH…